Literature DB >> 9080655

Differentiation of mesenchymal limb bud cells to chondrocytes in alginate beads.

M Shakibaei1, P De Souza.   

Abstract

Many in vitro models of embryonic material used for the cultivation of chondrocytes yield mixed cultures consisting of chondrocytes and fibroblast-like cells. For the optimization of cartilage cell cultures, alginate, a semisolid medium, was employed to obtain pure chondrocyte cultures. Isolated mesenchymal cells from 12-day-old mouse limb buds were grown in alginate for up to 4 weeks. A sub-population of the cells differentiated to chondrocytes and exhibited a stable phenotype until the end of the culture period. After 3 to 4 days a cartilage-specific matrix started to develop. Fibroblast-like cells from this mixed culture did not survive; they became necrotic. When alginate was later on dissolved by chelating agents, only chondrocytes were isolated. During dissolution of alginate and centrifugation, chondrocytes did not lose their contact with their new matrix present on their surfaces. Cultivation of these chondrocytes or chondrones in mass culture yields a pure chondrocyte population. Immunoelectron microscopic investigations revealed collagen type II, fibronectin, decorin and chondroitin sulfate-proteoglycans in the chondrocyte capsules and in mass culture.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9080655     DOI: 10.1006/cbir.1996.0119

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  26 in total

1.  A hydrophobically-modified alginate gel system: utility in the repair of articular cartilage defects.

Authors:  Mohammad Kazem Ghahramanpoor; Sayed Alireza Hassani Najafabadi; Majid Abdouss; Fatemeh Bagheri; Mohamadreza Baghaban Eslaminejad
Journal:  J Mater Sci Mater Med       Date:  2011-07-21       Impact factor: 3.896

2.  A hypothesis for the origin and pathogenesis of rheumatoid diseases.

Authors:  Wolfgang Lorenz; Gerold Sigrist; Mehdi Shakibaei; Ali Mobasheri; Christoph Trautmann
Journal:  Rheumatol Int       Date:  2005-12-14       Impact factor: 2.631

3. 

Authors:  Odile Gabay; Christelle Sanchez; Juan M Taboas
Journal:  Rev Rhum Ed Fr       Date:  2010-07-01

4.  Sirt-1 is required for the inhibition of apoptosis and inflammatory responses in human tenocytes.

Authors:  Franziska Busch; Ali Mobasheri; Parviz Shayan; Ralf Stahlmann; Mehdi Shakibaei
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

5.  Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor.

Authors:  M Shakibaei; T John; P De Souza; R Rahmanzadeh; H J Merker
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

6.  Cultivation of human tenocytes in high-density culture.

Authors:  G Schulze-Tanzil; A Mobasheri; P D Clegg; J Sendzik; T John; M Shakibaei
Journal:  Histochem Cell Biol       Date:  2004-08-27       Impact factor: 4.304

7.  Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells.

Authors:  Constanze Buhrmann; Franziska Busch; Parviz Shayan; Mehdi Shakibaei
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

8.  Enzymatically cross-linked alginic-hyaluronic acid composite hydrogels as cell delivery vehicles.

Authors:  Nitya Ganesh; Craig Hanna; Shantikumar V Nair; Lakshmi S Nair
Journal:  Int J Biol Macromol       Date:  2013-01-26       Impact factor: 6.953

9.  [Interaction between human chondrocytes and extracellular matrix in vitro: a contribution to autologous chondrocyte transplantation].

Authors:  M Shakibaei; C Csaki; M Rahmanzadeh; R Putz
Journal:  Orthopade       Date:  2008-05       Impact factor: 1.087

10.  Evidence that TNF-β induces proliferation in colorectal cancer cells and resveratrol can down-modulate it.

Authors:  Constanze Buhrmann; Mina Yazdi; Bastian Popper; Parviz Shayan; Ajay Goel; Bharat B Aggarwal; Mehdi Shakibaei
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.